Professor Gordon Dougan
Head of Pathogen Research
Member of the Board of Management
Honorary Professor Cambridge University
Adjunct Professor Monash University
The Wellcome Trust Sanger Institute
The Wellcome Trust Genome Campus
Hinxton, Cambridgeshire CB10 1SA
United Kingdom
Professor Gordon Dougan is currently employed on the faculty of the Wellcome Trust Sanger Institute, a world-leading Institute for research on genome biology. His research team investigates host/pathogen interactions associated with enteric bacterial pathogens, principally S. enterica serovar Typhi. He currently acts as a consultant and/or advisor for several charitable, government and industrial groups, such as chairing the Scientific Advisory Board for Novartis Vaccines, one of the biggest vaccine manufacturers in the world.
The Dougan lab has expertise in comparative genomics particularly in using population structures of enteric pathogens to link genotype to phenotype, in basic molecular microbiology, and in using frontier technologies applied to study host susceptibility to infection. This includes the establishment at Monash University of technology for probing human macrophage responses to bacterial pathogens, including antibiotic-resistant "superbugs".
